Intas Biopharmaceuticals Ltd - (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Intas Biopharmaceuti

Based on:

M-Cap below 100cr DeciZen not available

Intas Biopharmaceuticals Ltd - (Amalgamated) stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Intas Biopharmaceuti:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11TTM
ROCE % -4.6%3%11.5%15.5%5.2%5.8%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 6.626.147.889.480.888.288
Sales YoY Gr.-296.5%83.1%87.1%-9.6%9.1%-
Adj EPS -768.4-7.857.262.13.95.40
YoY Gr.-NANA8.5%-93.8%39.4%-
BVPS (₹) 4,167110.7307.2333.3335.94380
Adj Net
Profit
-3.8-1.51118.91.24.30
Cash Flow from Ops. 14.58.9126.4-83.7-
Debt/CF from Ops. 29.413.97.68.527.3-1.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA68.1%22.7%9.1%
Adj EPS NANA-54.5%39.4%
BVPSNA-36.3%12.6%30.4%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11TTM
Return on
Equity %
-16.9-6.823.520.211.80
Op. Profit
Mgn %
-19.519.134.434.521.633.7NAN
Net Profit
Mgn %
-58.4-5.722.921.21.54.80
Debt to
Equity
1.42.90.90.91.50.3-
Working Cap
Days
01411461542815180
Cash Conv.
Cycle
0161241112740

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Intas Biopharmaceuticals Ltd - (Amalgamated)

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 88.2 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 339 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 40.2

Management X-Ray of Intas Biopharmaceuti:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Intas Biopharmaceuti - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Intas Biopharmaceuti

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11
Sales6.5826.0947.7789.3880.8388.20
Operating Expenses 7.8821.1531.3658.9663.8458.47
Manufacturing Costs1.403.334.727.829.9110.37
Material Costs2.387.038.2323.6023.2319.54
Employee Cost 1.574.687.339.7212.4311.66
Other Costs 2.536.1111.0817.8218.2716.89
Operating Profit -1.294.9416.4130.4216.9929.72
Operating Profit Margin (%) -19.7%18.9%34.3%34.0%21.0%33.7%
Other Income 0.090.070.882.342.850.79
Interest 0.761.763.314.8810.059.41
Depreciation 1.202.984.425.076.699.40
Exceptional Items 000000
Profit Before Tax -3.160.279.5522.813.1011.70
Tax 0.691.78-1.434.202.247.43
Profit After Tax -3.85-1.5210.9818.610.854.27
PAT Margin (%) -58.5%-5.8%23.0%20.8%1.1%4.8%
Adjusted EPS (₹)-769.0-7.957.361.02.85.4
Dividend Payout Ratio (%)0%0%0%1%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11

Equity and Liabilities

Shareholders Fund 20.8321.1872.16114.88115.68347.13
Share Capital 0.051.9115.2516.3816.387.92
Reserves 20.7819.2756.9198.5099.30339.20
Minority Interest000000
Debt29.1662.1368.18101.60175.1290.62
Long Term Debt29.1662.1368.18101.60175.1290.62
Short Term Debt000000
Trade Payables3.598.709.6013.7622.0311.45
Others Liabilities 12.8314.9514.8822.3829.6830.24
Total Liabilities 66.41106.97164.82252.62342.50479.43

Fixed Assets

Gross Block45.7163.0774.92105.59120.24159.64
Accumulated Depreciation4.507.4811.9016.9423.6032.95
Net Fixed Assets 41.2155.5963.0288.6496.65126.68
CWIP 17.1032.8367.6897.71155.76149.93
Investments 1.213.996.2812.9612.9624.45
Inventories2.156.2711.3513.8522.6120.25
Trade Receivables2.655.675.5223.2332.3912.20
Cash Equivalents 0.210.653.642.153.631.43
Others Assets 1.881.987.3414.0718.50144.49
Total Assets 66.41106.97164.82252.62342.50479.43

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11
Cash Flow From Operating Activity 0.994.488.9411.976.41-83.65
PBT -3.160.279.5722.833.1011.70
Adjustment 1.974.787.559.3116.2318.66
Changes in Working Capital 2.21-0.32-8.31-18.96-10.5-112.66
Tax Paid -0.02-0.190.14-1.19-2.37-1.34
Cash Flow From Investing Activity -9.63-35.32-48.87-66.32-71.80-44.73
Capex -9.63-33.09-46.69-60.71-72.76-33.62
Net Investments 000000
Others 0-2.23-2.18-5.620.97-11.11
Cash Flow From Financing Activity 8.5631.2842.7452.8766.87126.18
Net Proceeds from Shares 0.0504024.330216.06
Net Proceeds from Borrowing 006.0533.429.25-47.11
Interest Paid -0.76-1.70-3.31-4.88-10.05-12.88
Dividend Paid 000-00-0
Others 9.2732.980067.67-29.89
Net Cash Flow -0.090.442.81-1.491.48-2.21

Finance Ratio

PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11
Ratios
ROE (%)-18.47-7.2127.4623.210.841.9
ROCE (%)-4.62311.515.525.155.77
Asset Turnover Ratio0.10.310.350.430.270.21
PAT to CFO Conversion(x)N/AN/A0.810.647.54-19.59
Working Capital Days
Receivable Days13957435912692
Inventory Days1135867518289
Payable Days551319406181281313

Intas Biopharmaceuticals Ltd - (Amalgamated) Stock News

Intas Biopharmaceuticals Ltd - (Amalgamated) FAQs

The current trading price of Intas Biopharmaceuti on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Intas Biopharmaceuti stood at ₹0.00.
The latest P/E ratio of Intas Biopharmaceuti as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Intas Biopharmaceuti as of 31-Dec-1969 is 0.00.
The 52-week high of Intas Biopharmaceuti is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Intas Biopharmaceuti is ₹88.20 ( Cr.) .

About Intas Biopharmaceuticals Ltd - (Amalgamated)

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×